ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Amgen Inc

Amgen Inc (AMGN)

0.00
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

AMGN Latest News

Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Me

Denosumab Trial Met Primary and All Secondary Endpoints by Significantly Delaying Time to First Skeletal Related Event and Significantly Reducing First-and-Subsequent Skeletal Related Events...

Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share

Fourth Quarter 2009 Revenue Increased 2 Percent to $3.8 Billion; Full Year 2009 Revenue Decreased 2 Percent to $14.6 Billion Fourth Quarter 2009 GAAP Earnings Per Share Increased 6 Percent to...

Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium

THOUSAND OAKS, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in...

Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results

THOUSAND OAKS, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that it plans to report its fourth quarter and full year financial results on Monday, Jan. 25, 2010...

Amgen Donates $2 Million, Establishes Earthquake Relief Program

Company, Staff Contributions To Help Haitian Victims THOUSAND OAKS, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that the company will donate $2 million to Haiti...

Amgen to Present at the 28th Annual JP Morgan Healthcare Conference

THOUSAND OAKS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) will present at the 28th Annual JP Morgan Global Healthcare Conference at 8:00 a.m. Pacific Time on Tuesday, Jan. 12...

Amgen Resolves EPO Patent Dispute With Roche

Roche Admits Infringement And Validity Of Amgen's EPO Patents; Court Enters Permanent Injunction; Amgen Allows Roche's MIRCERA Onto U.S. Market In Mid-2014 THOUSAND OAKS, Calif., Dec. 22...

Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines

THOUSAND OAKS, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) announced today that Roger M. Perlmutter, M.D., Ph. D., Amgen's executive vice president of Research & Development...

Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

THOUSAND OAKS, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that its board of directors has authorized repurchases of up to an additional $5 billion in Amgen...

New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists

Applications for 2010 Amgen Scholars U.S. and Europe Programs Now Available THOUSAND OAKS, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Each year, hundreds of undergraduate students from across the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

AMGN - Frequently Asked Questions (FAQ)

What is the current Amgen share price?
The current share price of Amgen is 0.00 €
What is the 1 year trading range for Amgen share price?
Amgen has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WHQF25High Quality Food Spa
0.033 €
(65.00%)
55k
AATAA Tech SpA
0.795 €
(30.33%)
255k
WERFOLaboratorio Farmaceutico Erfo SPA
0.0414 €
(29.78%)
730
WAMB26Ambromobiliare SpA
0.05 €
(25.00%)
10k
1VBKVerbio SE
12.15 €
(24.04%)
315
WTFINTrevi Finanziaria Industriale Spa
0.75 €
(-25.00%)
13.45k
EPHEPH SpA
0.104 €
(-22.96%)
88.29k
BIROEstrima Spa
0.354 €
(-17.29%)
166.8k
MNLMonnalisa SPA
1.61 €
(-14.36%)
222.48k
1NKLANikola Corp
1.17 €
(-11.48%)
100
TITTelecom Italia SpA
0.2495 €
(1.18%)
89.45M
SPMSaipem Spa
2.657 €
(5.90%)
45.64M
ISPIntesa Sanpaolo Spa
3.846 €
(-0.44%)
42.27M
BPEBper Banca SPA
5.942 €
(-3.13%)
21.54M
TITRTelecom Italia
0.2908 €
(0.45%)
13.93M

Discussion

View Full Feed
HotterMama HotterMama 25 seconds ago
Sarcasm....again!
OPTI
Golden Cross Golden Cross 34 seconds ago
Better volume early today...Looking up here... $ILST
ILST
trunkmonk trunkmonk 55 seconds ago
3.50 is a tough one.
FNMA
I ll be back I ll be back 1 minute ago
The 1-SA filing link:

https://www.sec.gov/Archives/edgar/data/1144392/000147793224008377/mgon_1sa.htm
MGON
trunkmonk trunkmonk 1 minute ago
what do you bet that Thompson will play ball with ending conserve or get more than half her staff at FHFA whacked.
FNMA
TheHound TheHound 2 minutes ago
I can see why! Alt season is near.
XRPUSD
powerbattles powerbattles 2 minutes ago
$BNRG round 2 cometh...BULLISH
BNRG
ducci1 ducci1 2 minutes ago
Covered 1/2 584P .92!
SPY
manibiotech manibiotech 2 minutes ago
Lol
Rest of that financing is by selling shares at discount = dilution + more dilution  . 
But that will need basic understanding of finance . 
NWBO
RedShoulder RedShoulder 2 minutes ago
1 1/2 hrs in, the current volume surpasses the avg vol.
Volume
1,585,291
Avg. Volume
1,568,572
AVXL
work-n-hard work-n-hard 2 minutes ago
FFIE: Launching 3.3 + 35%
FFIE
kickedoffagain kickedoffagain 3 minutes ago
NY, SS .... yup! It's like the guy (T.T.) is incapable of self-awareness / embarrassment.
APRU
powerbattles powerbattles 3 minutes ago
$BNRG round 2 cometh...
BNRG
LakeshoreLeo1953 LakeshoreLeo1953 3 minutes ago
It WOULD depend upon "intelligent" use of that tool.
I doubt there are ANY short positions currently that were
initiated and not covered below say about $9.
Even those likely would require more "collateral" than perhaps the
majority of portfolios here.
AVXL
ducci1 ducci1 3 minutes ago
Looks like wants to Test Da Floor at 5868.86 ??
SPY
stervc stervc 3 minutes ago
GCAN SEC Filings: https://www.otcmarkets.com/stock/GCAN/disclosure
GCAN
glenn1919 glenn1919 3 minutes ago
muln......................smackthebottom................................https://stockcharts.com/h-sc/ui?s=muln&p=W&yr=1&mn=3&dy=0&id=p96837884856
cootcat cootcat 3 minutes ago
The big question is when do people start taken profit?
IQST
otcsource otcsource 3 minutes ago
OTCN on ask/dil. Watch for floor/small bounce perhaps and Resistance settling IMO! deep into trips perhaps.
TWOH
manibiotech manibiotech 3 minutes ago
Please do so . 
NWBO
al44 al44 4 minutes ago
WSJ: ‘Green’ energy execs race to Washington D.C. to shore up support with a new PR pitch before Trump’s inauguration

By Olivia Murray


This change in strategy insinuates that even the industry itself recognizes that it’s not “clean and affordable” — which is the
manysevens manysevens 4 minutes ago
APDN .25's even nicer!
APDN
Evergreen Plateau Evergreen Plateau 4 minutes ago
Based upon recent reports.. should be at 15 to 20 cents book minimum ? Or more..
Way undervalued here
Took a starter at the ask
Filled at .015 range, shares are tight
FDCT
Nextbigone Nextbigone 4 minutes ago
MATH=BTC play for 2025 

With the price of Bitcoin surging 140% in 2024 — reaching the $100K milestone predicted by extreme bulls just 2 years ago — interest in Bitcoin stocks are increasing. The market cap of Bitcoin is over $2 trillion, bolstered in 2024 by the crypto-friendly presid
CYFRF DEFTF IBKR

Your Recent History

Delayed Upgrade Clock